Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomics
PGx implementation in Dutch pharmacies is hindered by structural barriers such as fragmented ICT and lack of reimbursement, despite strong professional support. Embedding PGx into pharmacy workflows and aligning policy, infrastructure, and education are essential. These findings may inform broader efforts to integrate PGx into pharmacies across diverse systems.
Authors
- Janet L. Mentink
- Naomi T. Jessurun (ORCID: https://orcid.org/0000-0002-8267-1259)
- Pantea Kiani (ORCID: https://orcid.org/0000-0003-3073-9749)
- Jesse J. Swen (ORCID: https://orcid.org/0000-0002-3965-5552)
- Petra Hoogland
- Sander D. Borgsteede (ORCID: https://orcid.org/0000-0002-8425-6139)
- Pierre M. Bet (ORCID: https://orcid.org/0000-0001-6735-7379)
Institutions
- University of Groningen (NL)
- Utrecht University (NL)
- American Pharmacists Association (US)
- Leiden University Medical Center (NL)
- Pharmo Institute (NL)
- Netherlands Pharmacovigilance Centre Lareb (NL)
- Post Apotheke (DE)
- Public Health Service of Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1007/s11096-025-02022-x
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00